Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study.

Eun Ha KangYinzhu JinAngela Y TongRishi J DesaiSeoyoung C Kim

Published in: Arthritis care & research (2020)

In this real-world cohort of RA patients, we noted no substantially different risk of any serious infection, bacterial infection, or herpes zoster after initiating TNFi plus MTX versus triple therapy, although CIs were wide.

Keyphrases

rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
disease activity
chronic kidney disease
peritoneal dialysis
prognostic factors
low dose
bone marrow